secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ovid Therapeutics Inc. (OVID)
CIK:        0001636651
Form:       8-K
Filed at:   2022-06-10T23:59:59+00:00
Accession:  0000950170-22-011472
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Ovid Therapeutics annual meeting elects two directors, ratifies KPMG
--------------------------------------------------------------------

- Annual meeting held June 9, 2022; 58.53% quorum (41,220,715 of 70,417,345 shares).
- Kevin Fitzgerald elected: 23,339,939 for, 76,303 withheld; broker non-votes 17,804,473.
- Bart Friedman elected: 17,204,205 for, 6,212,037 withheld; broker non-votes 17,804,473.
- Ratification of KPMG as auditor for FY2022: 40,049,679 for, 1,157,936 against, 13,100 abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1636651/000095017022011472/0000950170-22-011472-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1636651/000095017022011472/ovid-20220609.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-011472

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer